These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 8929412)

  • 1. Myc and Max homologs in Drosophila.
    Gallant P; Shiio Y; Cheng PF; Parkhurst SM; Eisenman RN
    Science; 1996 Nov; 274(5292):1523-7. PubMed ID: 8929412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mga, a dual-specificity transcription factor that interacts with Max and contains a T-domain DNA-binding motif.
    Hurlin PJ; Steingrìmsson E; Copeland NG; Jenkins NA; Eisenman RN
    EMBO J; 1999 Dec; 18(24):7019-28. PubMed ID: 10601024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc.
    Blackwood EM; Eisenman RN
    Science; 1991 Mar; 251(4998):1211-7. PubMed ID: 2006410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and properties of a Myc derivative that efficiently homodimerizes.
    Soucek L; Helmer-Citterich M; Sacco A; Jucker R; Cesareni G; Nasi S
    Oncogene; 1998 Nov; 17(19):2463-72. PubMed ID: 9824157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dominant-negative mutant of Max that inhibits sequence-specific DNA binding by Myc proteins.
    Billaud M; Isselbacher KJ; Bernards R
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2739-43. PubMed ID: 8464883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myc and Max: molecular evolution of a family of proto-oncogene products and their dimerization partner.
    Atchley WR; Fitch WM
    Proc Natl Acad Sci U S A; 1995 Oct; 92(22):10217-21. PubMed ID: 7479755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drosophila Myc is oncogenic in mammalian cells and plays a role in the diminutive phenotype.
    Schreiber-Agus N; Stein D; Chen K; Goltz JS; Stevens L; DePinho RA
    Proc Natl Acad Sci U S A; 1997 Feb; 94(4):1235-40. PubMed ID: 9037036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc.
    Gupta K; Anand G; Yin X; Grove L; Prochownik EV
    Oncogene; 1998 Mar; 16(9):1149-59. PubMed ID: 9528857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discrimination between different E-box-binding proteins at an endogenous target gene of c-myc.
    Desbarats L; Gaubatz S; Eilers M
    Genes Dev; 1996 Feb; 10(4):447-60. PubMed ID: 8600028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into the mechanism of heterodimerization from the 1H-NMR solution structure of the c-Myc-Max heterodimeric leucine zipper.
    Lavigne P; Crump MP; Gagné SM; Hodges RS; Kay CM; Sykes BD
    J Mol Biol; 1998 Aug; 281(1):165-81. PubMed ID: 9680483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low molecular weight inhibitors of Myc-Max interaction and function.
    Yin X; Giap C; Lazo JS; Prochownik EV
    Oncogene; 2003 Sep; 22(40):6151-9. PubMed ID: 13679853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The basic region/helix-loop-helix/leucine zipper domain of Myc proto-oncoproteins: function and regulation.
    Lüscher B; Larsson LG
    Oncogene; 1999 May; 18(19):2955-66. PubMed ID: 10378692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites.
    Zervos AS; Gyuris J; Brent R
    Cell; 1993 Jan; 72(2):223-32. PubMed ID: 8425219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variant Max protein, derived by alternative splicing, associates with c-Myc in vivo and inhibits transactivation.
    Arsura M; Deshpande A; Hann SR; Sonenshein GE
    Mol Cell Biol; 1995 Dec; 15(12):6702-9. PubMed ID: 8524235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myc-Max heterodimers activate a DEAD box gene and interact with multiple E box-related sites in vivo.
    Grandori C; Mac J; Siëbelt F; Ayer DE; Eisenman RN
    EMBO J; 1996 Aug; 15(16):4344-57. PubMed ID: 8861962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the Myc and Max interaction specificity with lambda repressor-HLH domain fusions.
    Marchetti A; Abril-Marti M; Illi B; Cesareni G; Nasi S
    J Mol Biol; 1995 May; 248(3):541-50. PubMed ID: 7752223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. X-ray structures of Myc-Max and Mad-Max recognizing DNA. Molecular bases of regulation by proto-oncogenic transcription factors.
    Nair SK; Burley SK
    Cell; 2003 Jan; 112(2):193-205. PubMed ID: 12553908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visualization of Myc/Max/Mad family dimers and the competition for dimerization in living cells.
    Grinberg AV; Hu CD; Kerppola TK
    Mol Cell Biol; 2004 May; 24(10):4294-308. PubMed ID: 15121849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The transcriptional repressor dMnt is a regulator of growth in Drosophila melanogaster.
    Loo LW; Secombe J; Little JT; Carlos LS; Yost C; Cheng PF; Flynn EM; Edgar BA; Eisenman RN
    Mol Cell Biol; 2005 Aug; 25(16):7078-91. PubMed ID: 16055719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Both the helix-loop-helix and the leucine zipper motifs of c-Myc contribute to its dimerization specificity with Max.
    Davis LJ; Halazonetis TD
    Oncogene; 1993 Jan; 8(1):125-32. PubMed ID: 8423990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.